MétaCan
Menu
Back to cohort
Record W4283739051 · doi:10.3233/jad-215483

Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions

2022· review· en· W4283739051 on OpenAlexafffund
Luis Agüera-Ortíz, Ganesh M. Babulal, Marie‐Andrée Bruneau, Byron Creese, Fabrizia D’Antonio, Corinne E. Fischer, Jennifer R. Gatchel, Zahinoor Ismail, Sanjeev Kumar, William J. McGeown, Moyra E. Mortby, Nicolás A. Núñez, Fabricio Ferreira de Oliveira, Arturo X. Pereiro, Ramit Ravona‐Springer, Hillary J Rouse, Huali Wang, Krista L. Lanctôt

Bibliographic record

VenueJournal of Alzheimer s Disease · 2022
Typereview
Languageen
FieldMedicine
TopicTreatment of Major Depression
Canadian institutionsSunnybrook Health Science CentreCentre for Addiction and Mental HealthOntario Brain InstituteUniversity of TorontoUniversity of CalgarySt. Michael's HospitalUniversité de MontréalMontreal Heart Institute
FundersNational Institute of General Medical SciencesNational Health and Medical Research CouncilWeston Brain InstituteCanadian Institutes of Health ResearchNational Institutes of HealthUniversity of TorontoFundação de Amparo à Pesquisa do Estado de São PauloDepartment of Psychiatry, University of TorontoBrightFocus FoundationFondation Brain CanadaNational Institute on AgingAlzheimer's AssociationConsortium canadien en neurodégénérescence associée au vieillissementMedical Research Council
KeywordsDementiaPsychosisClinical trialPsychological interventionPsychologyNeuroimagingPsychiatrySchizophrenia (object-oriented programming)Adverse effectMedicinePsychotherapistDiseasePathology

Abstract

fetched live from OpenAlex

Psychotic phenomena are among the most severe and disruptive symptoms of dementias and appear in 30% to 50% of patients. They are associated with a worse evolution and great suffering to patients and caregivers. Their current treatments obtain limited results and are not free of adverse effects, which are sometimes serious. It is therefore crucial to develop new treatments that can improve this situation. We review available data that could enlighten the future design of clinical trials with psychosis in dementia as main target. Along with an explanation of its prevalence in the common diseases that cause dementia, we present proposals aimed at improving the definition of symptoms and what should be included and excluded in clinical trials. A review of the available information regarding the neurobiological basis of symptoms, in terms of pathology, neuroimaging, and genomics, is provided as a guide towards new therapeutic targets. The correct evaluation of symptoms is transcendental in any therapeutic trial and these aspects are extensively addressed. Finally, a critical overview of existing pharmacological and non-pharmacological treatments is made, revealing the unmet needs, in terms of efficacy and safety. Our work emphasizes the need for better definition and measurement of psychotic symptoms in dementias in order to highlight their differences with symptoms that appear in non-dementing diseases such as schizophrenia. Advances in neurobiology should illuminate the development of new, more effective and safer molecules for which this review can serve as a roadmap in the design of future clinical trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.965
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.004
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.195
GPT teacher head0.448
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designOther design
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations28
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Alzheimer s DiseaseSame topicTreatment of Major DepressionFrench-language works237,207